NiKang Therapeutics biopharma start-up gets $50 million in Series B funding

Delaware Business Now

Sep 23, 2020

NiKang Therapeutics, Inc., a biotech company, announced the completion of Series B financing for $50 million led by RTW Investments, LP with additional support from new investors i…